From Bench to Bedside – Recent Advances in Drug Delivery to Cancer

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/20

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 10:23 AM on 4/15/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

21 Terms

1
New cards

What is paclitaxel’s mechanism of action?

It stabilises microtubules, preventing depolymerisation → cell cycle arrest.

2
New cards

Why is Cremophor EL used in paclitaxel formulations?

Paclitaxel is water‑insoluble; CrEL solubilises it.

3
New cards

What major issue is associated with Cremophor EL?

 Severe anaphylactic hypersensitivity reactions (up to 35% without premedication).

4
New cards

What is nabpaclitaxel (Abraxane)?

A solventfree, albuminbound nanoparticle formulation of paclitaxel.

5
New cards

Why does albumin bind paclitaxel effectively?

Albumin contains hydrophobic pockets that bind hydrophobic drugs.

6
New cards

What receptor mediates nabpaclitaxel transcytosis?

gp60 on endothelial cells → activates caveolin‑1.

7
New cards

What is the EPR effect?

Tumour vasculature is leaky and has poor lymphatic drainage → nanoparticles accumulate passively.

8
New cards
<p><strong>What is clathrin</strong><span style="font-family: &quot;Cambria Math&quot;;"><strong>‑</strong></span><strong>mediated endocytosis? </strong></p>

What is clathrinmediated endocytosis?

Receptormediated uptake via ~100 nm clathrincoated vesicles that internalize nanoparticles into the early endosome. These vesicles later fuse with endosomes for sorting.

9
New cards
<p><span><strong><span>What is caveolin</span></strong></span><span style="font-family: &quot;Cambria Math&quot;;"><strong><span>‑</span></strong></span><span><strong><span>mediated endocytosis?</span></strong></span></p>

What is caveolinmediated endocytosis?

Uptake via 50–80 nm caveolae (small  flask-shaped invaginations rich in cholesterol and sphingolipids) that bypass lysosomes avoiding degradation.

 

10
New cards

What is clathrin/caveolinindependent uptake?

 Uptake via small dynamic membrane domains; avoids degradation.

11
New cards

How does PEGylation affect phagocytosis?

Reduces opsonisation, helping nanoparticles evade immune clearance.

12
New cards

Why is the transferrin receptor (TfR) a good cancer target?

Cancer cells overexpress TfR due to high iron demand.

13
New cards

 What is a Nuclear Localization Signal (NLS)?

A short amino acid sequence directing molecules into the nucleus.

14
New cards

 What is TPP (Triphenylphosphonium) used for?

Mitochondrial targeting due to its lipophilic cationic nature.

15
New cards

How does TPP (Triphenylphosphonium) achieve mitochondrial targeting?

Its lipophilic cationic nature allows accumulation driven by the negative mitochondrial membrane potential, enabling selective mitochondrial delivery.

16
New cards

How does gp60–caveolin1 signalling enhance nabpaclitaxel tumour penetration?

Albumin binds gp60, activating caveolin1, which triggers caveolae formation → enhanced transcytosis across endothelial cells.

17
New cards

Why is caveolinmediated uptake advantageous for organelle targeting?

It bypasses lysosomal degradation, allowing nanoparticles to reach the Golgi or ER, improving intracellular delivery efficiency.

18
New cards

 What is the main limitation of clathrinmediated endocytosis for nanomedicine?

Cargo is trafficked to lysosomes, where many nanoparticles undergo enzymatic degradation, reducing bioavailability.

19
New cards

Why is endosomal escape critical for gene delivery systems like SGT‑53?

Without escape, genetic cargo becomes trapped in endosomes → lysosomes, preventing nuclear delivery of p53 cDNA.

20
New cards

Why is the nuclear pore complex a major barrier for nanomedicine?

it restricts passive diffusion to <10 nm, meaning most nanoparticles require NLS peptides or active transport mechanisms.

21
New cards

What makes disulfide linkers suitable for redoxresponsive nanomedicine?

Tumours have high intracellular GSH, which reduces disulfide bonds → drug release. This exploits tumourspecific redox imbalance.